1 study found for:    22418699 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: anastrozole;   Drug: gefitinib;   Drug: fulvestrant;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years